| |
original article |
Date |
Title |
Authors Max. 6 Authors |
| 1 |
[GO] |
2026―Feb―28 |
Metabolism-dependent endocrine regulation of TMPRSS2 gene expression (rs12329760): proteomic networks and functional pathways of interaction in COVID-19","Метаболізмзалежна ендокринна регуляція експресії гена TMPRSS2 (rs12329760): протеомні мережі та функціональні шляхи взаємодії при COVID-19 |
L. Sydorchuk, M. Sokolenko, V. Vasiuk, V. Dzhuryak, A. Gutnitska, L. Honcharuk, D. Sobko, Y. Karavan |
| 2 |
[GO] |
2025―Sep―29 |
Post COVID-19 structural, functional and immune changes of the thyroid in patients with autoimmune thyroiditis |
Yu.V. Buldygina, A.H. Haletska, H.M. Terekhova, S.L. Shlyakhtych, Yu.I. Belyakova |
| 3 |
[GO] |
2025―Jan―04 |
Study of cardiovascular risk in type 2 diabetic patients in the acute phase of the coronavirus infection and post-COVID period on the background of therapy with sodium-glucose cotransporter-2 inhibitors |
N.M. Kushnarоva, O.V. Zinych, A.A. Shuprovych, K.P. Komisarenko |
| 4 |
[GO] |
2024―Sep―27 |
The effect of COVID-19 on the presentation of thyroid antibodies. Case report |
Afrim Zeqiraj |
| 5 |
[GO] |
2024―Jan―09 |
Erectile function in men with COVID-19 six months after recovery |
E.V. Luchytskyi, V.E. Luchytskyi, G.A. Zubkova, V.M. Rybalchenko, I.I. Skladanna |
| 6 |
[GO] |
2023―Oct―31 |
Diabetes mellitus and COVID-19: living with double risk |
O.V. Muravlova, Z.O. Shaienko, I.L. Dvornyk, L.M. Sizova, V.I. Ilchenko, T.I. Purdenko, O.A. Shpetnyi |
| 7 |
[GO] |
2023―Apr―29 |
Hyporeninemic hypoaldosteronism as a manifestation of autonomic neuropathy in a patient with type 2 diabetes mellitus against the background of coronavirus disease. A clinical case |
N.O. Pertseva, T.V. Chursinova, A.A. Gryshniakova |
| 8 |
[GO] |
2022―Oct―11 |
Why is the mortality rate high in RT-PCR negative COVID-19 patients with comorbid diseases? |
Mümtaz Taner Torun, Dilber Yilmaz Durmaz |
| 9 |
[GO] |
2022―Apr―22 |
Hypercortisolism on the background of recovery of COVID-19 (сase report) |
V. Kravchenko, O. Rakov, L.V. Slipachuk |
| 10 |
[GO] |
2021―Oct―29 |
Treatment of neurological complications in patients with type 2 diabetes mellitus at the stage of rehabilitation after COVID-19 |
V.I. Pankiv |
| 11 |
[GO] |
2021―Oct―20 |
Effects of COVID-19 and diabetes mellitus on apolipoprotein A1 level in the blood plasma of patients |
V.V. Pushkarev, L.K. Sokolova, S.A. Cherviakova, Yu.B. Belchina, M.V. Bigun, O.I. Kovzun, V.M. Pushkarev, M.D. Tronko |
| 12 |
[GO] |
2021―Oct―20 |
Diabetic ketoacidosis precipitated by COVID-19 in patient with newly diagnosed diabetes mellitus |
E. Xhardo, P. Kapisyzi, A. Rada |
| 13 |
[GO] |
2021―Aug―20 |
Pathophysiological and clinical aspects of interaction between coronavirus disease 2019 and thyroid |
V.I. Pankiv, N.V. Pashkovska, I.V. Pankiv, V.A. Maslyanko, I.O. Tsaryk |
| 14 |
[GO] |
2021―May―14 |
Compliance to levothyroxine treatment of the patients with hypothyroidism during SARS-CoV-2 pandemic era |
Satilmis Bilgin, Burcin Meryem Atak Tel, Tuba Taslamacioglu Duman, Ozge Kurtkulagi, Gizem Bakir Kahveci, Tugrul Sagdic, Gulali Aktas |
| 15 |
[GO] |
2021―Apr―06 |
Clinical characteristics of covid-19 patients at King Saud Medical City: a retrospective study |
Marwah Bin Talib, Abdullah A. Baredhwan, Khaled Alenazi, Ali Almagooshi, Abdulrehman M. Alqahtani, Sultan A. Alsobayeg, Sarah Alhazmi, Waad Awad, Ameera S. Alamri, Parameaswari P. Jaganathan, Manasik N. Abdu, Latif Ahmed Khan |
| 16 |
[GO] |
2020―Dec―29 |
COVID-19: a new etiological factor of Graves’ disease? |
A.M. Urbanovych, F.V. Laniush, O.Z. Lishchuk, K.Yu. Kozlovska |
| 17 |
[GO] |
2020―Aug―28 |
COVID-19 and diabetes mellitus: management of patients during the pandemic |
N.V. Pashkovska, V.I. Pankiv, O.V. Pashkovska |
